Showing results (341-350 of 474) with videos related to
Sort By:
Pageof 48
Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 9, 2026
Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-blinded, Randomized Clinical TrialDouglas R Morgan, Ricardo L Dominguez, Dalton A Norwood, et al.Integrative Cancer Therapies|January 3, 2026
The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence SynthesisSarah Benna-Doyle, Suzanne Grant, Alison Maunder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2011
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging systemMin Yi, Elizabeth A Mittendorf, Janice N Cormier, et al.Cancer Research|August 14, 2015
Perivascular M2 Macrophages Stimulate Tumor Relapse after ChemotherapyRussell Hughes, Bin-Zhi Qian, Charlotte Rowan, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 15, 2021
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2Douglas F Lake, Alexa J Roeder, Erin Kaleta, et al.EMBO Molecular Medicine|December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancerYun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.The Journal of Experimental Medicine|March 21, 2012
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibitionDai Horiuchi, Leonard Kusdra, Noelle E Huskey, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 2025
"Interpreters don't tell you everything": experiences with medical interpretation among Latino cancer patients and caregivers with limited English proficiencyEleanor Brown, Min Young Kim, Zaria N Cosby, et al.Pageof 48